Fast-growing, high-quality, owner-operator stock ðŸ§
Interesting stock. This one even held up in the bear market of 2022.
Yes, it is quite impressive.
Great company bad investement at this price
So the big questo i clients
Small pharma needs angel investors, usualy coing from private equty.
The money can ran out way quiker than what it looks like to fund new drug development.
The moat in this case goes away.
It is a risky busness and should be treated as such
Good point. Medpace can be more cyclical in that manner than other more stable quality companies.
Interesting stock. This one even held up in the bear market of 2022.
Yes, it is quite impressive.
Great company bad investement at this price
So the big questo i clients
Small pharma needs angel investors, usualy coing from private equty.
The money can ran out way quiker than what it looks like to fund new drug development.
The moat in this case goes away.
It is a risky busness and should be treated as such
Good point. Medpace can be more cyclical in that manner than other more stable quality companies.